Scientists Hopeful About Early Study Combining Oncolytic Virus, CAR T – Managed Markets Network

Anti-CD19 CAR T-cell treatment acts on the B cell antigen CD19, but not all tumors have a naturally occurring antigen that is uniformly present on tumor cells but not normal tissues.

Researchers at the City of Hope genetically engineered

source website